A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study
Sponsor: Kolon Life Science
Listed as NCT05613569, this observational or N/A phase trial focuses on Lumbosacral Radiculopathy and remains ongoing. Sponsored by Kolon Life Science, it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting
Status: Enrolling By Invitation → Active Not Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Enrolling By Invitation
-
Dec 2022 — Jul 2024 [monthly]
Enrolling By Invitation
First recorded
Jul 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Kolon Life Science
For direct contact, visit the study record on ClinicalTrials.gov .